U.S. stock futures are lower this morning. Futures for the Dow Jones Industrial Average dropped 39 points to 12,155, while those for the S&P 500 index declined 6.1 points to 1,313. Futures for the Nasdaq 100 index lost 7.75 points to 2,354.

Shares of Nokia (NOK) dropped in pre-market trading as the company unveiled partnership with Microsoft (MSFT).

Negative sentiment ruled the European markets today. While STOXX Europe 600 Index has dropped 0.42%, London's FTSE 100 Index moved down 0.27%.

Our recommendations for the Buyback Premium Portfolio center on a collection of five stocks that we believe, as a group, will outperform the market this month.

The Buyback Premium Portfolio has beat the S&P 500 by more than 72% since its inception (August 2, 2000)! It is up 54.87% since inception vs. a decline of 17.90% in the S&P 500. For the month of November, the portfolio gained 3.41% vs. a decline of 0.23% in the S&P 500.

Analyst Upgrades

• Sprint (S) was upgraded to neutral from underweight at Piper Jaffray.
• Cree (CREE) was upgraded to outperform from market perform at Morgan Keegan.
• Brocade (BRCD) was upgraded to outperform from market perform at JMP Securities.
• JPMorgan upgraded WuXi PharmaTech (WX) to overweight from neutral.
• Barclays upgraded ITC Holdings (ITC) to overweight from equal weight.
• Centene (CNC) was upgraded to outperform from underperform at Oppenheimer.
• Senior Housing (SNH) was upgraded to buy from hold at Jefferies.
• UBS upgraded Hovnanian (HOV) to neutral from sell.
• GeoResources (GEOI) was upgraded to accumulate from neutral at Madison Williams.
• Compellent (CML) was upgraded to hold from sell at Canaccord.

Analyst Upgrades

• Jefferies upgraded Computer Sciences (CSC) to buy from hold and raised its target to $53 from $47. The analyst said Computer Sciences' valuation has created one of the best LBO opportunities in several years and could provide a five year IRR of 25+%.
• Keefe Bruyette upgraded Comerica (CMA) to outperform from market perform, citing strength of the company's capital. The firm raised its target for shares to $44 from $43.
• RBC Capital upgraded Nokia (NOK) to outperform from sector perform and raised its price target to $14 from $12. The firm upgraded shares based on valuation, reduced execution risk on software development, and potential catalysts from new devices based on Symbian^3. RBS upgraded Nokia to buy from hold after the company named Stephen Elop as CEO.
• Allstate (ALL) was upgraded to buy from hold at Citigroup.
• Coca-Cola Enterprises (CCE) was upgraded to buy from neutral at BofA/Merrill.
• Moody's (MCO) was upgraded to overweight from neutral at Piper Jaffray.

Analyst upgrades:

• Wells Fargo upgraded Prudential (PRU) to outperform from market perform. The firm thinks the company is in a better position than its peers and will be able to more effectively exploit M&A opportunities.
• UBS upgraded Reliance Steel (RS) to buy from neutral based on potential growth through M&A and valuation. The firm raised its target to $50 from $49.
• Deutsche Bank upgraded Eastman Chemical (EMN) to buy from hold on expectations the company's portfolio transformation will drive higher normalized earnings power, which the firm believes is not fully reflected in consensus estimates. Deutsche raised its target price on shares to $70 from $62.
• Amylin Pharma (AMLN) was upgraded to overweight from equal weight at Barclays.
• Cephalon (CEPH) was upgraded to buy from hold at Jefferies.
• Acuity Brands (AYI) was upgraded to outperform from perform at Oppenheimer.

Analyst upgrades:

• Janney Montgomery upgraded Adobe (ADBE) to buy from neutral on expectations for a strong CS5 product cycle in 2010. The firm raised its target on shares to $43 from $33.
• Kaufman Bros. upgraded Rackspace (RAX) to buy from hold to reflect the company's "strong" Q3 results and expectations growth will accelerate in 2010. The firm raised its target on shares to $22.50 from $16. Oppenheimer upgraded Rackspace to outperform from perform and established a $24 price target on the stock.
• Stephens upgraded Ann Taylor (ANN) to overweight from equal weight as it believes the company's core brand will recover faster than originally thought. The firm raised its target on shares to $17 from $12.
• Rockwell (ROK) was upgraded to neutral from underperform at Baird.
• Taiwan Semi (TSM) was raised to outperform from market perform at FBR Capital.
• Royal Bank of Scotland (RBS) was upgraded to buy from hold at Deutsche Bank.

Pepsi Bottling Group (NYSE: PBG), a beverage entity that competes with Coca-Cola (NYSE: KO) and Coca-Cola Enterprises (NYSE: CCE), reported Q2 earnings on Wednesday. Adjusting for a gain related to tax issues, the company earned 78 cents per share.

According to Trey Thoelcke's earnings preview, Pepsi Bottling Group was only supposed to make about 73 cents per share. So, management managed to beat Wall Street's projections. Unfortunately, management made the same amount of per-share profit in the year-ago period, so there wasn't any growth on the bottom line.

Analyst upgrades:

• Baird upgraded URS Corp. (NYSE: URS) to Outperform from Neutral and raised its target to Outperform from Neutral based on momentum of new wins from stimulus funds and expectations for additional nuclear contracts.
• Jefferies upgraded EnerSys (NYSE: ENS) to Buy from Hold following the recent share weakness as it believes volumes have stopped declining and the June quarter is likely the bottom. The firm raised its target price to $18 from $11.
• RBC Capital upgraded Camden Property (NYSE: CPT) to Outperform from Sector Perform citing the company's improved financial capacity and portfolio position. The firm raised its target price to $34 from $23.
• CBS Corp (NYSE: CBS) was upgraded to Equal Weight from Underweight at Barclays.
• UDR (NYSE: UDR) was raised to Sector Perform from Underperform at RBC Capital and to Outperform from Market Perform at Keefe Bruyette.
• Zale (NYSE: ZLC) was upgraded to Buy from Neutral at BofA/Merril.

Analyst upgrades:

• Oppenheimer upgraded FTI Consulting (NYSE:FCN) to Outperform from Perform on expectations the stock will outperform in the second half of 2009 due to easier comparisons and a "deeper and longer" restructuring cycle. The firm has a $62 target on shares.
• Citigroup upgraded Cigna (NYSE:CI) to Hold from Sell to reflect reduced balance sheet risk following the company's capital raise and the potential for a PBM sale. The firm raised its target price to $23 from $13.
• Goldman expects Coca-Cola Enterprises (NYSE:CCE) to benefit from favorable soda demand and lower commodity costs. The firm upgraded shares to Conviction Buy from Buy and has a $20 target on the stock.
• Novellus (NASDAQ:NVLS) was raised to Buy from Neutral at Bank of America/Merrill.
• CME Group (NASDAQ:CME) was upgraded at JP Morgan to Neutral from Underweight.
• Allegiant (NASDAQ:ALGT) was upgraded to Overweight from Equal Weight at Morgan Stanley.
  

• Goldman upgraded Gerdau AmeriSteel (NYSE: GNA) to Buy from Neutral and has a $5.50 target on shares. Shares were upgraded due to the potential impact from infrastructure spending. Note that Goldman downgraded Steel Dynamics (NYSE: STLD) and Olympic Steel (NYSE: ZEUS) to Neutral from Buy.
  
• Banc of America/Merrill upgraded Coca-Cola Enterprises (NYSE: CCE) to Buy from Neutral and raised the price target to $18 from $15. The firm the strong Q1 report gives them greater confidence in shares.
  
• Roth Capital upgraded Halozyme (NASDAQ: HALO) to Buy from Hold due to increased clarity into Roche programs, the discontinuation of the chemophase program, and progress on insulin delivery.
• American Movil (NYSE: AMX) was raised to Overweight from Neutral at JP Morgan and to Hold from Sell at Citigroup.
  
• Barclays (NYSE: BCS) and Lloyds TSB Group (NYSE: LYG) were upgraded at HSBC to Overweight from Neutral.

Coca-Cola (NYSE: KO) reported first-quarter earnings on Tuesday morning. By the end of the day, the main enemy of PepsiCo (NYSE: PEP) was down 2.8% on better-than-average volume. Coke said that it earned 65 cents per share on an adjusted basis. According to Beth Gaston Moon's earnings preview, management met Wall Street's expectations.

So, right off the bat, you can see why the market wasn't so kind to Coke's shares. Meeting expectations isn't enough sometimes. But there are some other issues here, too.

Revenue was kind of soft, and a look at the statement of cash flows shows a decrease in money generated from operations. That number decreased over 20% to roughly $870 million.

• KeyBanc upgraded Greenbrier (NYSE: GBX) to Buy from Hold as it believes the company has options to forestall covenant violations or bankruptcy, event if conditions deteriorate further.
  
• Friedman Billings upgraded Whole Foods (NASDAQ: WFMI) to Market Perform from Underperform citing low expectations, favorable FTC settlement, progress on cost cutting, and valuation.
  
• JP Morgan believes First Merit (NASDAQ: FMER) is one of the best positioned Midwest banks to weather the storm and notes its compelling valuation and capital levels. The firm upgraded shares to Overweight from Neutral.
• Coca-Cola Enterprises (NYSE: CCE) was raised to Buy from Neutral at Goldman.
  
• Newell Rubbermaid (NYSE: NWL) was upgraded to Buy from Neutral at Banc of America/Merrill.
  
• Compass Minerals (NYSE: CMP) was lifted to Outperform from Perform at Oppenheimer.

Coca-Cola (NYSE: KO), the arch rival of PepsiCo (NYSE: PEP), is set to report Q4 numbers on Thursday, February 12. Coke is estimated to earn 61 cents per share, a growth of about 5%. Is it doable? More importantly, will Coke be able to beat projections? I'd say it might, considering that the two major bottlers out there, Pepsi Bottling Group (NYSE: PBG) and Coca-Cola Enterprises (NYSE: CCE), both beat on their respective bottom lines this week. Pepsi Bottling trounced expectations by 5 cents, and Coke's bottler did better by 3 cents.

Not that the quarter will have been a cake walk. There will be issues with currency translations and the global slowdown. Even though Coke sells products that are theoretically defensive against a recession, I imagine that guidance will be conservative, and I would bet that growth in case volume, a very important metric for beverage companies, will be down. I'll hope for the best, but I'm bracing myself for that outcome.

It's about that time again: Pepsi vs. Coke. No, not another taste test or another Battle of the Brands. It's time for the next quarterly results from these two soft drink titans.

Analysts surveyed by Thomson Reuters anticipate that PepsiCo Inc. (NYSE: PEP), global beverage and snack food giant, will report fourth-quarter earnings this week that are 9.1% higher that a year ago, or $0.88 per share. Revenue is expected to total $12.8 billion, which is 3.9% higher than last year. For the full year, the profit is expected to be $3.67 per share on revenue of $43.4 billion, up from $3.38 per share on $39.5 billion in 2007. PepsiCo's earnings met or beat estimates in four of the past five quarters, but missed by only two cents per share in the third quarter. The consensus recommendation of analysts remains to buy PEP. The share price fell to a 52-week low in January and is now 24.4% lower than it was a year ago. During the fourth quarter, PepsiCo declared a $0.42 per share quarterly dividend, agreed to acquire a Spitz International, and announced investments in China and Mexico.